Affected by COVID-19 pandemic, we stopped manufacturing and followed the recommended sterilising procedures.  We resumed manufacturing on 14 February 2020 and our operation are back to normal levels within several days.
We adopt a “checks and balances” policy in management, and we ensure “effectiveness and efficiency” are in place. 
We always maintain close contact with our vendors, clients and business partners through cloud meetings. We monitor the developments and react to the changes timely.
Thanks to the cooperation and hard work by our employees.
We wish to create the maximum rewards to our investors, customers, employees and business partners.